Satyaki Ganguly
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Satyaki Ganguly has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
Sheela Kuruvila
Department of Dermatology, Venereology and Leprosy, Pondicherry Institute of Medical Sciences, Puducherry, India
12 shared publicationsKranti C Jaykar
Department of Dermatology, Venereology and Leprosy, Katihar Medical College, Katihar, Bihar, India
3 shared publicationsNamrata Chhabra
Department of Dermatology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India
3 shared publicationsNeel Prabha
Department of Dermatology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India
3 shared publicationsRajesh Kumar
Department of Pathology, Katihar Medical College, Katihar, Bihar, India
3 shared publicationsAdaikalampillai Ganapathy Vikramkumar
Department of Dermatology, Venereology and Leprosy, Pondicherry Institute of Medical Sciences, Puducherry, India
2 shared publications
Latest Publications
- Open Access
- 2 October 2025
- Published by Springer Nature in Cureus
- Vol. 17 (10)
Monocyte to High-Density Lipoprotein Ratio (MHR) and Monocyte to Lymphocyte Ratio (MLR) in Vitiligo: A Case-Control Study
Background Vitiligo is a disorder influenced by oxidative stress and systemic inflammation. While previous studies used difficult-to-perform markers, research on readily available markers like the monocyte to high-density lipoprotein ratio (MHR), monocyte to lymphocyte ratio (MLR), platelet to lymphocyte ratio (PLR), and neutrophil to lymphocyte ratio (NLR) for oxidative stress in vitiligo remains limited, and assessing these markers in stable and unstable vitiligo represents a novel area of research. Materials and methods This case-control study was conducted on 72 vitiligo patients and an equal number of age and gender-matched healthy controls. Out of 72 vitiligo patients, 57 patients had unstable vitiligo and 15 patients had stable vitiligo. Complete blood count (CBC) and fasting lipid profile (FLP) were performed for both cases and controls to assess MHR, MLR, NLR, and PLR. Further, 19 patients on systemic therapy were reassessed after one month. Their ratios were compared before and after treatment. Results Vitiligo patients had significantly higher MHR, MLR, NLR, and PLR as compared to healthy controls. Compared to controls, stable vitiligo patients had no significant difference in these markers. Only PLR was significantly higher in unstable compared to stable vitiligo patients. There was no statistically significant reduction in these markers after one month of systemic treatment in 19 patients.
- 2 October 2025
- Published by Springer Nature in Cureus
- Vol. 17 (10)
Open AccessMonocyte to High-Density Lipoprotein Ratio (MHR) and Monocyte to Lymphocyte Ratio (MLR) in Vitiligo: A Case-Control Study
Background Vitiligo is a disorder influenced by oxidative stress and systemic inflammation. While previous studies used difficult-to-perform markers, research on readily available markers like the monocyte to high-density lipoprotein ratio (MHR), monocyte to lymphocyte ratio (MLR), platelet to lymphocyte ratio (PLR), and neutrophil to lymphocyte ratio (NLR) for oxidative stress in vitiligo remains limited, and assessing these markers in stable and unstable vitiligo represents a novel area of research. Materials and methods This case-control study was conducted on 72 vitiligo patients and an equal number of age and gender-matched healthy controls. Out of 72 vitiligo patients, 57 patients had unstable vitiligo and 15 patients had stable vitiligo. Complete blood count (CBC) and fasting lipid profile (FLP) were performed for both cases and controls to assess MHR, MLR, NLR, and PLR. Further, 19 patients on systemic therapy were reassessed after one month. Their ratios were compared before and after treatment. Results Vitiligo patients had significantly higher MHR, MLR, NLR, and PLR as compared to healthy controls. Compared to controls, stable vitiligo patients had no significant difference in these markers. Only PLR was significantly higher in unstable compared to stable vitiligo patients. There was no statistically significant reduction in these markers after one month of systemic treatment in 19 patients.
- 11 August 2025
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 57, 100954
Subcutaneous phaeohyphomycosis due to a rare fungus Parathyridaria percutanea: First reported case from central India
- 11 August 2025
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 57, 100954
Subcutaneous phaeohyphomycosis due to a rare fungus Parathyridaria percutanea: First reported case from central India
- Open Access
- 28 February 2025
- Published by Scientific Scholar in Journal of Cutaneous and Aesthetic Surgery
- Vol. 19, 55-63
Efficacy and safety of intralesional Candida albican s antigen versus intralesional mumps, measles, rubella vaccine in the treatment of multiple cutaneous warts: A double-blinded randomized controlled trial
Objectives: This study aimed to compare the efficacy and safety of intralesional C. albicans antigen with intralesional MMR vaccine in the treatment of multiple cutaneous warts in patients aged above 12 years. Material and Methods: This was a double-blinded randomized control trial on sixty patients with multiple cutaneous warts. Treatment group 1 received intralesional C. albicans antigen and treatment group 2 received intralesional MMR vaccine. Each patient was given a total of 0.3 mL of antigen divided into the two largest warts at week 0, 2, and 4 and followed up at week 8. Efficacy was assessed by complete response rates, distal response rates, and response rates of injected warts. Safety was assessed by the rate of adverse events occurring with either of the treatment modalities. Results: Out of the sixty patients, 53 patients completed the study. The complete therapeutic response rate was 37.5% and 34.48% in treatment groups 1 and 2, respectively. The mean time taken to achieve complete clearance of warts was 7.33 ± 2.000 weeks and 7.2 ± 1.687 weeks, respectively. Treatment group 1 showed a significantly higher rate of side effects compared to treatment group 2. Conclusion: Intralesional immunotherapy with Candida and MMR both showed similar efficacy, and MMR was found to be relatively safer than C. albicans antigen.
- 28 February 2025
- Published by Scientific Scholar in Journal of Cutaneous and Aesthetic Surgery
- Vol. 19, 55-63
Open AccessEfficacy and safety of intralesional Candida albican s antigen versus intralesional mumps, measles, rubella vaccine in the treatment of multiple cutaneous warts: A double-blinded randomized controlled trial
Objectives: This study aimed to compare the efficacy and safety of intralesional C. albicans antigen with intralesional MMR vaccine in the treatment of multiple cutaneous warts in patients aged above 12 years. Material and Methods: This was a double-blinded randomized control trial on sixty patients with multiple cutaneous warts. Treatment group 1 received intralesional C. albicans antigen and treatment group 2 received intralesional MMR vaccine. Each patient was given a total of 0.3 mL of antigen divided into the two largest warts at week 0, 2, and 4 and followed up at week 8. Efficacy was assessed by complete response rates, distal response rates, and response rates of injected warts. Safety was assessed by the rate of adverse events occurring with either of the treatment modalities. Results: Out of the sixty patients, 53 patients completed the study. The complete therapeutic response rate was 37.5% and 34.48% in treatment groups 1 and 2, respectively. The mean time taken to achieve complete clearance of warts was 7.33 ± 2.000 weeks and 7.2 ± 1.687 weeks, respectively. Treatment group 1 showed a significantly higher rate of side effects compared to treatment group 2. Conclusion: Intralesional immunotherapy with Candida and MMR both showed similar efficacy, and MMR was found to be relatively safer than C. albicans antigen.
- Open Access
- 11 September 2024
- Published by Medknow in Journal of Family Medicine and Primary Care
- Vol. 13 (9) , 3887-3891
Dapsone-induced haemolysis among leprosy patients on MDT from an endemic area of central India
Background and Aim: Haemolysis due to dapsone as a part of MDT in leprosy patients has been long recognized. However, the frequency and severity of this side effect and factors associated with it have not been well documented. We planned to determine the frequency of dapsone-induced haemolysis in leprosy patients on MDT and various risk factors associated with it. Materials and Methods: This was a hospital-based retrospective analysis, conducted on 36 treatment completed or partially treated or on treatment leprosy patients in a tertiary care centre in Chhattisgarh. Results: Out of 36 patients, 83.3% showed a fall in haemoglobin from the baseline value (pre-treatment values). Dapsone was stopped in 33.3% of patients with a significant fall in haemoglobin. We found that the mean haemoglobin concentration for all patients fell from 13.05(+/−1.8) g/dl to 11.8(+/−1.9) g/dl (P < 0.05) which was statistically significant. A total of 25% of patients were labelled as confirmed cases of dapsone-induced haemolysis as per our definition. Conclusion: Our results underline the need to incorporate haematological investigations in leprosy management protocol, especially in primary care settings where the majority of leprosy patients are managed.
- 11 September 2024
- Published by Medknow in Journal of Family Medicine and Primary Care
- Vol. 13 (9) , 3887-3891
Open AccessDapsone-induced haemolysis among leprosy patients on MDT from an endemic area of central India
Background and Aim: Haemolysis due to dapsone as a part of MDT in leprosy patients has been long recognized. However, the frequency and severity of this side effect and factors associated with it have not been well documented. We planned to determine the frequency of dapsone-induced haemolysis in leprosy patients on MDT and various risk factors associated with it. Materials and Methods: This was a hospital-based retrospective analysis, conducted on 36 treatment completed or partially treated or on treatment leprosy patients in a tertiary care centre in Chhattisgarh. Results: Out of 36 patients, 83.3% showed a fall in haemoglobin from the baseline value (pre-treatment values). Dapsone was stopped in 33.3% of patients with a significant fall in haemoglobin. We found that the mean haemoglobin concentration for all patients fell from 13.05(+/−1.8) g/dl to 11.8(+/−1.9) g/dl (P < 0.05) which was statistically significant. A total of 25% of patients were labelled as confirmed cases of dapsone-induced haemolysis as per our definition. Conclusion: Our results underline the need to incorporate haematological investigations in leprosy management protocol, especially in primary care settings where the majority of leprosy patients are managed.
- Open Access
- 1 July 2024
- Published by Medknow in Indian Journal of Dermatology
- Vol. 69 (4) , 354-355
Irritant Contact Dermatitis from Accidental Exposure to a Kitchen Degreaser
- 1 July 2024
- Published by Medknow in Indian Journal of Dermatology
- Vol. 69 (4) , 354-355
Open AccessIrritant Contact Dermatitis from Accidental Exposure to a Kitchen Degreaser
- Open Access
- 1 April 2024
- Published by Wolters Kluwer Health in International Journal of Mycobacteriology
- Vol. 13 (2) , 178-182
Mycobacterium welchii Vaccine Granuloma – A Cautionary Tale
Background: Mycobacterium welchii (Mycobacterium w) vaccine was one of the many strategies used to both treat and prevent coronavirus disease 2019 (COVID-19) infection. We report the results of a retrospective analysis of 15 cases with vaccine-site granulomas after administration of prophylactic Mycobacterium w vaccine as part of a trial for COVID-19 and our experience in managing those cases. Methods: This was a retrospective analysis of 15 patients with vaccine-site granulomas who were given the vaccine as a prophylactic measure as part of a trial with informed consent. Results: The mean average age of cases was 37 and the male-to-female ratio was 1:0.87. All of the patients developed erythematous tender nodules over the injection sites within a month of receiving the inoculations. Mycobacterial cultures and cartridge-based nucleic acid amplification tests yielded negative results. Skin biopsy revealed granulomatous dermatitis with acid-fast bacilli positivity. A diagnosis of noninfective granulomatous dermatitis was made. Treatment started with analgesics and anti-inflammatory agents. Systemic antibiotics were required in 9/15 patients. Patients are being followed up with no reported recurrence till date. Conclusion: The possibility of injection-site granuloma should be taken into the risk–benefit analysis for the administration of Mycobacterium w vaccine and the patients should be counseled as such. Patients with persistent ulceration respond to combinations of doxycycline, ofloxacin, and clarithromycin.
- 1 April 2024
- Published by Wolters Kluwer Health in International Journal of Mycobacteriology
- Vol. 13 (2) , 178-182
Open AccessMycobacterium welchii Vaccine Granuloma – A Cautionary Tale
Background: Mycobacterium welchii (Mycobacterium w) vaccine was one of the many strategies used to both treat and prevent coronavirus disease 2019 (COVID-19) infection. We report the results of a retrospective analysis of 15 cases with vaccine-site granulomas after administration of prophylactic Mycobacterium w vaccine as part of a trial for COVID-19 and our experience in managing those cases. Methods: This was a retrospective analysis of 15 patients with vaccine-site granulomas who were given the vaccine as a prophylactic measure as part of a trial with informed consent. Results: The mean average age of cases was 37 and the male-to-female ratio was 1:0.87. All of the patients developed erythematous tender nodules over the injection sites within a month of receiving the inoculations. Mycobacterial cultures and cartridge-based nucleic acid amplification tests yielded negative results. Skin biopsy revealed granulomatous dermatitis with acid-fast bacilli positivity. A diagnosis of noninfective granulomatous dermatitis was made. Treatment started with analgesics and anti-inflammatory agents. Systemic antibiotics were required in 9/15 patients. Patients are being followed up with no reported recurrence till date. Conclusion: The possibility of injection-site granuloma should be taken into the risk–benefit analysis for the administration of Mycobacterium w vaccine and the patients should be counseled as such. Patients with persistent ulceration respond to combinations of doxycycline, ofloxacin, and clarithromycin.
- Open Access
- 16 September 2022
- Published by Springer Nature in Cureus
- Vol. 14 (9) , e29218
Rare Co-Existent Dermatitis Herpetiformis and Psoriasis in a Child: A Causal Relationship?
Dermatitis herpetiformis (DH) is an auto-inflammatory skin disease that is linked to gluten sensitivity and is related to celiac disease (CD). Psoriasis is an inflammatory skin disorder found to have an association with the celiac disease, according to various genetic and epidemiological studies. We report a 12-year-girl who presented with multiple tense blisters along with red raised, scaly and itchy lesions over her body. She was a known case of psoriasis and was diagnosed as dermatitis herpetiformis in an immunofluorescence study. In this case report, we want to highlight the fact that the co-existence of dermatitis herpetiformis and psoriasis could be more than a mere coincidence. In our patient's previously uncontrolled psoriasis and dermatitis herpetiformis both improved after a gluten-free diet along with systemic therapy.
- 16 September 2022
- Published by Springer Nature in Cureus
- Vol. 14 (9) , e29218
Open AccessRare Co-Existent Dermatitis Herpetiformis and Psoriasis in a Child: A Causal Relationship?
Dermatitis herpetiformis (DH) is an auto-inflammatory skin disease that is linked to gluten sensitivity and is related to celiac disease (CD). Psoriasis is an inflammatory skin disorder found to have an association with the celiac disease, according to various genetic and epidemiological studies. We report a 12-year-girl who presented with multiple tense blisters along with red raised, scaly and itchy lesions over her body. She was a known case of psoriasis and was diagnosed as dermatitis herpetiformis in an immunofluorescence study. In this case report, we want to highlight the fact that the co-existence of dermatitis herpetiformis and psoriasis could be more than a mere coincidence. In our patient's previously uncontrolled psoriasis and dermatitis herpetiformis both improved after a gluten-free diet along with systemic therapy.
- Open Access
- 1 May 2022
- Published by Medknow in Indian Journal of Dermatology
- Vol. 67 (3) , 313
An Analysis of Interns’ Feedback after Dermatology Posting
Background: Dermatology knowledge among fresh medical graduates is poor in India as undergraduate medical curriculum and Internship training lack adequate focus on this subject. This contributes to the inappropriate management of Dermatology patients by the medical graduates. Objective: To analyse the expectations, motivations and experience of interns during their dermatology posting. Materials and Methods: This was a retrospective record review of questionnaire-based anonymous validated feedback forms submitted by interns posted in a dermatology department of a tertiary care institute. The feedback form contained nine multiple choice questions some of which allowed multiple responses. Results: A total of 63 completed forms were analysed. The common expectations before the posting were, to learn the management of basic dermatological problems (98.4%), to take an informed decision regarding post-graduation in dermatology (53.9%) and hope that the posting will be useful for the postgraduate entrance test (50.7%). After the posting, 69.87% of them felt that their expectations were fulfilled. After the posting, 84.1% of the interns felt that they would have liked to study dermatology as a separate undergraduate subject with a summative assessment at the end. Limitations: The sample size was less and the feedback form contained limited questions. Conclusion: The majority of the interns were satisfied after dermatology posting. Increased exposure of interns to dermatology inpatients and side laboratory procedures will further enrich their clinical experience. The inclusion of dermatology as a separate subject with examination in the undergraduate curriculum was a felt need.
- 1 May 2022
- Published by Medknow in Indian Journal of Dermatology
- Vol. 67 (3) , 313
Open AccessAn Analysis of Interns’ Feedback after Dermatology Posting
Background: Dermatology knowledge among fresh medical graduates is poor in India as undergraduate medical curriculum and Internship training lack adequate focus on this subject. This contributes to the inappropriate management of Dermatology patients by the medical graduates. Objective: To analyse the expectations, motivations and experience of interns during their dermatology posting. Materials and Methods: This was a retrospective record review of questionnaire-based anonymous validated feedback forms submitted by interns posted in a dermatology department of a tertiary care institute. The feedback form contained nine multiple choice questions some of which allowed multiple responses. Results: A total of 63 completed forms were analysed. The common expectations before the posting were, to learn the management of basic dermatological problems (98.4%), to take an informed decision regarding post-graduation in dermatology (53.9%) and hope that the posting will be useful for the postgraduate entrance test (50.7%). After the posting, 69.87% of them felt that their expectations were fulfilled. After the posting, 84.1% of the interns felt that they would have liked to study dermatology as a separate undergraduate subject with a summative assessment at the end. Limitations: The sample size was less and the feedback form contained limited questions. Conclusion: The majority of the interns were satisfied after dermatology posting. Increased exposure of interns to dermatology inpatients and side laboratory procedures will further enrich their clinical experience. The inclusion of dermatology as a separate subject with examination in the undergraduate curriculum was a felt need.
- Open Access
- 18 March 2022
- Published by Medknow in Journal of Family Medicine and Primary Care
- Vol. 11 (4) , 1416-1420
Grade 2 disability among leprosy patients: A pilot study from an endemic area of Central India
Background and Aim: Deformities and disabilities in leprosy lead to significant morbidity to the individual and financial burden to the family. As the prevalence of leprosy is higher in central India, this study was conducted to know the burden of deformity and disability among leprosy patients in central India and the factors associated with it. Materials and methods: This was a hospital-based, cross-sectional study, conducted on 50 new or on treatment or released from treatment leprosy patients, attending the Dermatology OPD of a tertiary care institute in Central India. Disability was graded as per the WHO criteria for disability grading of hands and feet. Results: Grade 2 disability was found among 32% of the patients with leprosy, whereas a total of 60% of our patients had either grade 1 or grade 2 disabilities. Trophic ulcer was found among 20% and claw hand among 14% of leprosy patients. We found significant associations of lepromatous leprosy with trophic ulcer (p = 0.004) and grade 2 disability (p = 0.012). All patients with claw hands and 80% of the patients with trophic ulcers presented to the healthcare facility at least 6 months after the onset of symptoms. Conclusions: We found very high rates of disability and deformity among leprosy patients indicating possible huge burden of morbidity among leprosy patients in central India. The significant association of lepromatous leprosy with trophic ulcer and grade 2 disability indicated delayed presentation and diagnosis of lepromatous leprosy patients. Our results underlined the need for large scale community-based studies on disability and deformity among leprosy patients in Central India. These results also call for better training of primary level healthcare workers for early detection and management of deformities and disabilities as well as better patient education for leprosy patients regarding hand and foot care.
- 18 March 2022
- Published by Medknow in Journal of Family Medicine and Primary Care
- Vol. 11 (4) , 1416-1420
Open AccessGrade 2 disability among leprosy patients: A pilot study from an endemic area of Central India
Background and Aim: Deformities and disabilities in leprosy lead to significant morbidity to the individual and financial burden to the family. As the prevalence of leprosy is higher in central India, this study was conducted to know the burden of deformity and disability among leprosy patients in central India and the factors associated with it. Materials and methods: This was a hospital-based, cross-sectional study, conducted on 50 new or on treatment or released from treatment leprosy patients, attending the Dermatology OPD of a tertiary care institute in Central India. Disability was graded as per the WHO criteria for disability grading of hands and feet. Results: Grade 2 disability was found among 32% of the patients with leprosy, whereas a total of 60% of our patients had either grade 1 or grade 2 disabilities. Trophic ulcer was found among 20% and claw hand among 14% of leprosy patients. We found significant associations of lepromatous leprosy with trophic ulcer (p = 0.004) and grade 2 disability (p = 0.012). All patients with claw hands and 80% of the patients with trophic ulcers presented to the healthcare facility at least 6 months after the onset of symptoms. Conclusions: We found very high rates of disability and deformity among leprosy patients indicating possible huge burden of morbidity among leprosy patients in central India. The significant association of lepromatous leprosy with trophic ulcer and grade 2 disability indicated delayed presentation and diagnosis of lepromatous leprosy patients. Our results underlined the need for large scale community-based studies on disability and deformity among leprosy patients in Central India. These results also call for better training of primary level healthcare workers for early detection and management of deformities and disabilities as well as better patient education for leprosy patients regarding hand and foot care.
- Open Access
- 21 February 2022
- Published by Scientific Scholar in Indian Journal of Dermatology, Venereology and Leprology
- Vol. 88 (3) , 286-290
Coronavirus disease 2019 vaccination in patients with psoriasis: A position statement from India by SIG psoriasis (IADVL Academy)
Coronavirus disease 2019 (COVID-19) pandemic has affected every sphere of life including management of psoriasis. The availability of COVID-19 vaccines has given rise to hope and at the same time some apprehensions as well. With the general population becoming eligible for vaccination, there is some confusion, on the eligibility of patients with different medical conditions and patients on immunosuppressive or immunomodulating medications for COVID-19 vaccination. Dermatologists treating psoriasis patients frequently face questions from them, whether they can undergo coronavirus disease 2019 vaccination. A PUBMED search was performed using the following strategy: ‘COVID-19’ AND ‘Vaccine’ AND ‘Psoriasis’. We also performed a PUBMED search using the following strategy: ‘SARS-CoV-2’ AND ‘Vaccine’ AND ‘Psoriasis’. All articles irrespective of language and publication date were included to arrive at this position statement. This position statement deals with the safety, eligibility and modifications of treatment, if needed among psoriasis patients with regards to the coronavirus disease 2019 vaccines currently available in India.
- 21 February 2022
- Published by Scientific Scholar in Indian Journal of Dermatology, Venereology and Leprology
- Vol. 88 (3) , 286-290
Open AccessCoronavirus disease 2019 vaccination in patients with psoriasis: A position statement from India by SIG psoriasis (IADVL Academy)
Coronavirus disease 2019 (COVID-19) pandemic has affected every sphere of life including management of psoriasis. The availability of COVID-19 vaccines has given rise to hope and at the same time some apprehensions as well. With the general population becoming eligible for vaccination, there is some confusion, on the eligibility of patients with different medical conditions and patients on immunosuppressive or immunomodulating medications for COVID-19 vaccination. Dermatologists treating psoriasis patients frequently face questions from them, whether they can undergo coronavirus disease 2019 vaccination. A PUBMED search was performed using the following strategy: ‘COVID-19’ AND ‘Vaccine’ AND ‘Psoriasis’. We also performed a PUBMED search using the following strategy: ‘SARS-CoV-2’ AND ‘Vaccine’ AND ‘Psoriasis’. All articles irrespective of language and publication date were included to arrive at this position statement. This position statement deals with the safety, eligibility and modifications of treatment, if needed among psoriasis patients with regards to the coronavirus disease 2019 vaccines currently available in India.